Company profile: Boston Biomedical
1.1 - Company Overview
Company description
- Provider of biotechnology research and development focused on novel therapeutics to treat cancer.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Boston Biomedical
Cernostics
HQ: United States
Website
- Description: Provider of molecular diagnostic tests for cancer, leveraging its patent-protected TissueCypher platform. TissueCypher is a laboratory-developed test that analyzes tissue from Barrett's esophagus biopsies to provide a patient's five-year risk of progression to high-grade dysplasia or esophageal adenocarcinoma.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cernostics company profile →
Artiva Bio
HQ: United States
Website
- Description: Provider of allogeneic NK cell therapies and an umbilical cord blood–based manufacturing platform for off-the-shelf use. Products include AlloNK, a non-genetically modified NK therapy enhancing monoclonal antibody or NK engager activity in trials for autoimmune diseases and cancers; AB-201, a clinical-stage HER2-targeted CAR-NK for solid tumors; and AB-205, a preclinical CAR-NK for CD5+ T-cell lymphomas.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Artiva Bio company profile →
Tusk Therapeutics
HQ: United Kingdom
Website
- Description: Provider of immuno-oncology therapies, discovering and developing unique therapeutic antibodies that harness the immune system to treat cancer, with a growing, diversified pipeline targeting both novel and validated targets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tusk Therapeutics company profile →
Veraxa Biotech
HQ: Germany
Website
- Description: Provider of ADC development solutions, combining targeted antibody discovery and bioconjugation. Offerings include droplet-based microfluidics for functional antibody screening, site-specific conjugation via proprietary bioorthogonal click chemistry to create uniform, stable ADCs, Positional Intelligence genetic code expansion for precise payload placement, and charged payloads to enhance manufacturing, efficacy, pharmacokinetics, and safety.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Veraxa Biotech company profile →
Normunity
HQ: United States
Website
- Description: Provider of precision immuno-oncology medicines focused on immune normalizers—novel cancer immunotherapies that restore normal immune responses. Includes the Chen Lab Discovery Platform to identify and validate novel targets and Normunity Drug Development to create monoclonal antibodies based on these discoveries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Normunity company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Boston Biomedical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Boston Biomedical
2.2 - Growth funds investing in similar companies to Boston Biomedical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Boston Biomedical
4.2 - Public trading comparable groups for Boston Biomedical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →